Matthew Strobeck insider trades: Biodesix (BDSX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 5, 2024 | BDSX | ↑ Buy | 36,000 | $1.40 | $50K | By Birchview Fund LLC | Nov 6, 2024 (1d) |
| Nov 5, 2024 | BDSX | ↑ Buy | 4,000 | $1.40 | $6K | By Birchview Capital Separately Managed | Nov 6, 2024 (1d) |
| Mar 27, 2023 | AZYO | ↑ Buy | 140,000 | $1.48 | $207K | Indirect | Mar 27, 2023 (0d) |
| Dec 8, 2022 | AZYO | ↑ Buy | 97,261 | $4.09 | $398K | Indirect | Feb 13, 2023 (67d) |
| Nov 21, 2022 | BDSX | ↑ Buy | 1,365,217 | $1.15 | $1.6M | By Birchview Fund LLC | Nov 21, 2022 (0d) |
| Nov 21, 2022 | BDSX | ↑ Buy | 869,565 | $1.15 | $1000K | Direct | Nov 21, 2022 (0d) |
| Nov 21, 2022 | BDSX | ↑ Buy | 108,695 | $1.15 | $125K | By UTMA Account | Nov 21, 2022 (0d) |
| Apr 7, 2022 | BDSX | ↑ Buy | 558,659 | $1.79 | $1000K | By Birchview Fund LLC | Apr 11, 2022 (4d) |
| Apr 7, 2022 | BDSX | ↑ Buy | 558,659 | $1.79 | $1000K | Direct | Apr 11, 2022 (4d) |
| Dec 30, 2021 | BDSX | ↑ Buy | 138,700 | $4.35 | $603K | By Birchview Fund LLC | Jan 4, 2022 (5d) |
| Dec 30, 2021 | BDSX | ↑ Buy | 9,100 | $4.35 | $40K | By Birchview Capital Separately Managed | Jan 4, 2022 (5d) |
| Oct 30, 2020 | BDSX | ↑ Buy | 83,333 | $18.00 | $1.5M | By Birchview Fund LLC | Nov 3, 2020 (4d) |
| Sep 3, 2020 | QDEL | ↑ Buy | 7,700 | $166.07 | $1.3M | Birchview | Sep 4, 2020 (1d) |
| Mar 18, 2020 | AXDX | ↑ Buy | 10,000 | $7.11 | $71K | By Birchview Fund, LLC | Mar 20, 2020 (2d) |
| Jan 9, 2017 | AXDX | ↑ Buy | 8,000 | $19.00 | $152K | Through Birchview Fund, LLC | Jan 10, 2017 (1d) |
| Feb 9, 2016 | AXDX | ↑ Buy | 20,000 | $11.52 | $230K | Through Birchview Fund, LLC | Feb 10, 2016 (1d) |
| Dec 15, 2015 | AXDX | ↑ Buy | 88,235 | $17.00 | $1.5M | Through Birchview Fund, LLC | Dec 17, 2015 (2d) |
| Jun 19, 2015 | MBLX | ↑ Buy | 101,970 | $3.32 | $339K | Direct | Jun 23, 2015 (4d) |
| Jun 19, 2015 | MBLX | ↑ Buy | 43,700 | $3.32 | $145K | Owned by Birchview Fund LLC | Jun 23, 2015 (4d) |
| Mar 19, 2015 | AXDX | ↑ Buy | 2,000 | $22.04 | $44K | Through Birchview Fund, LLC | Mar 23, 2015 (4d) |
| Aug 5, 2014 | AXDX | ↑ Buy | 20,000 | $16.70 | $334K | Indirect | Aug 6, 2014 (1d) |
| Nov 29, 2013 | MBLX | ↑ Buy | 100,000 | $1.00 | $100K | Direct | Dec 2, 2013 (3d) |
| Nov 30, 2012 | MBLX | ↑ Buy | 155,000 | $1.10 | $171K | Direct | Dec 4, 2012 (4d) |
| May 11, 2012 | MBLX | ↑ Buy | 100,000 | $2.20 | $220K | Direct | May 14, 2012 (3d) |
| Mar 12, 2012 | MBLX | ↑ Buy | 100,000 | $3.12 | $312K | Direct | Mar 13, 2012 (1d) |
| Dec 16, 2008 | MBLX | ↑ Buy | 40,000 | $7.95 | $318K | Direct | Dec 17, 2008 (1d) |
| Jun 12, 2007 | MBLX | ↓ Sell | 39,765 | $20.84 | $829K | By Guggenheim Portfolio Company XIX, LLC | Jun 14, 2007 (2d) |
| Jun 12, 2007 | MBLX | ↓ Sell | 1,100 | $20.86 | $23K | By Guggenheim Portfolio Company, LLC | Jun 14, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BDSX insiders
Open-market trades in the last 12 months
About Matthew Strobeck's insider trades
Matthew Strobeck is an insider at Biodesix (BDSX). Since Jun 12, 2007, Matthew has reported 26 open-market purchases worth $12.7M and 2 sales worth $852K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (55 filings), option exercises (15 filings), other transactions (6 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BDSX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.